Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis
- 18 September 2002
- Vol. 21 (1-2) , 30-43
- https://doi.org/10.1016/s0264-410x(02)00444-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The Strange Case of Leishmania chagasiParasitology Today, 2000
- Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of LeishmaniadonovaniVaccine, 1999
- Safety Profile of Phase I and II Preventive HIV Type 1 Envelope Vaccination: Experience of the NIAID AIDS Vaccine Evaluation GroupAIDS Research and Human Retroviruses, 1997
- Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovaniVaccine, 1997
- Leishmaniasis research and the European UnionParasitology Today, 1995
- The Control of the Antibody Isotype Response to Recombinant Human Immunodeficiency Virus gp120 Antigen by AdjuvantsAIDS Research and Human Retroviruses, 1992
- Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro cultureParasite Immunology, 1992
- Leishmania infantum, the aetiological agent of american visceral Leishmaniasis (AVL)?Memórias do Instituto Oswaldo Cruz, 1987
- IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN LOCALISED CUTANEOUS LEISHMANIASISPublished by Elsevier ,1987
- Infecções experimentaes na Leishmaniose visceral americanaMemórias do Instituto Oswaldo Cruz, 1938